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MiceChronic drug exposure and drug withdrawal induce expressive neuronal plasticity which could be considered as
both functional and pathological responses. It is well established that neuronal plasticity in the limbic system
plays a pivotal role in relapse as well as in compulsive characteristics of drug addiction. Although increases in
FosB/DeltaFosB expression constitute one of the most important forms of neuronal plasticity in drug addiction,
it is unclear whether they represent functional or pathological plasticity. It is of noteworthy importance the indi-
vidual differences in the transition from recreational use to drug addiction. These differences have been reported
in studies involving the ethanol-induced locomotor sensitization paradigm. In the present studywe investigated
whether sensitized and non-sensitized mice differ in terms of FosB/DeltaFosB expression. Adult male outbred
Swissmicewere daily treatedwith ethanol or saline for 21 days. According to the locomotor activity in the acqui-
sition phase, they were classiﬁed as sensitized (EtOH_High) or non-sensitized (EtOH_Low). After 18 h or 5 days,
their brains were processed for FosB/DeltaFosB immunohistochemistry. On the 5th day of withdrawal, we could
observe increased FosB/DeltaFosB expression in the EtOH_High group (in the motor cortex), in the EtOH_Low
group (in the ventral tegmental area), and in both groups (in the striatum). Differences were more consistent
in the EtOH_Low group. Therefore, behavioral variability observed in the acquisition phase of ethanol-induced
locomotor sensitization was accompanied by differential neuronal plasticity during withdrawal period. Further-
more, distinct patterns of FosB/DeltaFosB expression detected in sensitized and non-sensitized mice seem to be
more related to withdrawal period rather than to chronic drug exposure. Finally, increases in FosB/DeltaFosB ex-
pression during withdrawal period could be considered as being due to both functional and pathological
plasticity.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
The challenge of current neurobiological research in drug addiction
is to understand the neuronal plasticity mechanisms that mediate the
transition from recreational use to the loss of behavioral control over
drug seeking and drug taking. One of the most important theories of
drug addiction, called “the dark side of addiction”, suggests that there
is a progression from impulsivity (related to positive reinforcement)
to compulsivity (related to negative reinforcement). This progression,
in a collapsed cycle, comprises the following states: preoccupation/an-
ticipation, binge intoxication, and withdrawal/negative affect (Koob
and Le Moal, 2005, 2008; Koob and Volkow, 2010). From this scenarioandar, São Paulo, SP 01221-020,
tos-Junior).
y.
ghts reserved.on, drug addiction studies have been focusing on the neurobiological
mechanisms related to negative emotional states emerging from both
acute and protracted abstinence. According to the theory of “the dark
side of addiction”, there seems to occur long-term and persistent plas-
ticity changes in neural circuits aiming to limit reward. However,
these plasticity alterations lead to a negative emotional state that
emergeswhen the access to the drug is prevented. Thismechanismpro-
vides a strong motivational drive for the establishment of addiction, as
well as, for its maintenance (Koob and Le Moal, 2005, 2008).
Locomotor sensitization is a useful animal model based on the fact
that increases on subjective effects of the drugs along their repeated ex-
posure are similar to increases in the drug-induced stimulant locomotor
effects (Vanderschuren and Kalivas, 2000; Vanderschuren and Pierce,
2010). Although locomotor sensitization does not mimic several behav-
iors related to drug addiction, its temporal morphological and neuro-
chemical features are in parallel with those leading the transition from
recreational use to drug addiction itself (Robinson and Kolb, 1999;
Vanderschuren and Kalivas, 2000; Vanderschuren and Pierce, 2010).
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acquisition (repeated drug exposure), withdrawal period and challenge
(a new contact with the drug after the withdrawal period). Unfortu-
nately, most of the studies using the locomotor sensitization focused
only in the acquisition and challenge phase, overlapping thewithdrawal
period.
It is well established that repeated exposure to drugs of abuse
(Perrotti et al., 2008) and chronic stress (Perrotti et al., 2004) increases
the expression of the transcription factor fosB/deltafosB in the
corticolimbic system. FosB/DeltaFosB accumulation in these regions
has been hypothesized to play a central role in the resilience to stress
(Berton et al., 2007; Vialou et al., 2010) and in the rewarding effects of
cocaine (Harris et al., 2007; Muschamp et al., 2012), ethanol (Kaste
et al., 2009; Li et al., 2010), and opioids (Zachariou et al., 2006; Solecki
et al., 2008). Therefore, it is possible that FosB/DeltaFosB modulates
some of the neuronal plasticity events related to the ethanol-induced lo-
comotor sensitization, as well as, the withdrawal that ensues the acqui-
sition phase of locomotor sensitization.
It is noteworthy that there are individual differences observed dur-
ing the transition from recreational use to drug addiction (Flagel et al.,
2009; George and Koob, 2010; Swendsen and LeMoal, 2011). For exam-
ple, DBA/2 J mice aremore prone to respond than C57BL/6 J to ethanol-
induced locomotor sensitization (Phillips et al., 1997; Melón and
Boehm, 2011a). In outbred Swiss mice, behavioral variability regarding
ethanol induced locomotor sensitization was ﬁrst described by Masur
and dos Santos (1988). From then on, other studies have demonstrated
important neurochemical features related to behavioral variability in
the acquisition of ethanol-induced locomotor sensitization (Souza-
Formigoni et al., 1999; Abrahão et al., 2011, 2012; Quadros et al.,
2002a, 2002b). However, these studies did not address the impact of be-
havioral variability during the withdrawal period after the acquisition
phase of locomotor sensitization. In a recent study, our laboratory de-
scribed a signiﬁcant difference between sensitized and non-sensitized
outbred Swiss mice regarding the expression of cannabinoid receptor
type 1 (CB1R) throughout withdrawal. In that study, sensitized (but
not non sensitizedmice) had increased CB1R expression in the prefron-
tal cortex, ventral tegmental area, amygdala, striatum, and hippocam-
pus (Coelhoso et al., 2013).
Given the well established behavioral variability in outbred Swiss
mice regarding ethanol-induced locomotor sensitization, and that this
variability is accompanied by distinct neurochemical features during
subsequent withdrawal, the present study investigated the expression
of FosB/DeltaFosB in sensitized andnon sensitizedmice at the beginning
(18 h) and after 5 days of withdrawal.2. Material and methods
2.1. Subjects
Male outbred Swiss Webster mice (EPM-1 Colony, São Paulo, SP,
Brazil), originally derived from the Albino Swiss Webster line from the
Center for the Development of Animal Models in Biology and Medicine
at the Universidade Federal de São Paulo, were used. Mice were
12 weeks of age (30–40 g) at the start of testing. Groups of 10 mice
were housed in cages (40 × 34 × 17 cm) with woodchip bedding.
The temperature (20–22 °C) and humidity (50%) controlled animal col-
ony was maintained on a light/dark cycle (12/12 h), with lights on at
07:00 h,withmouse chowpellets and tapwater ad libitum, except dur-
ing testing. Mice were maintained in these housing conditions for at
least 7 days prior to the beginning of drug treatment and behavioral
tests. Animal care and experimental procedures were conducted
under protocols approved by the Animal Care and Use Ethics Commit-
tee of the University (protocol number: 2043/09), according to EU Di-
rective 2010/63/EU for animal experiments (http://ec.europa.eu/
environmental/chemicals/lab_animals/legislation_en.htm).2.2. Locomotor sensitization
The protocol of locomotor sensitization was based on a previous
study from our own laboratory (Coelhoso et al., 2013). At the beginning
of the protocol, all animalswere injected intraperitoneally (i.p.)with sa-
line and immediately tested in an automated activity box (Insight,
Brazil) for 15 min to establish basal locomotion. Two days later, animals
were daily injected with ethanol (2 g/kg, 15% w/v in 0.9% NaCl, i.p. —
EtOH group, N = 40) or saline (similar volume, i.p., — Control group,
N = 12), during 21 days. Right after the 1st, the 7th, the 14th, and the
21st injections, animals were placed in the activity cage for 15 min.
The horizontal locomotion in each situation was measured by a behav-
ioral analysis system (Pan Lab, Spain). As expected (Masur and dos
Santos, 1988; Coelhoso et al., 2013), behavioral variability in the loco-
motor activity at the 21st day of acquisition allows us to distribute the
animals of EtOH group in 2 subgroups: EtOH_High (taken from the
upper 30% of the distribution) and EtOH_Low (taken from the lower
30% of the distribution). Thus, only the 60% of animals were included
in the analysis. This strategy is identical to those used in the studies in-
vestigating individual variability within the ethanol sensitization para-
digm (Masur and dos Santos, 1988; Souza-Formigoni et al., 1999;
Quadros et al., 2002a, 2002b; Abrahão et al., 2011, 2012; Coelhoso
et al., 2013).
After the classiﬁcation deﬁning the experimental groups, we per-
formed 2 independent experiments according to the temporal criteria
of withdrawal period: (i) animals submitted to the acquisition phase
and sacriﬁced after 18 h of withdrawal and (ii) animals submitted to
the acquisition phase and sacriﬁced after 5 days of withdrawal. So,
this study comprised 3 experimental groups (Control, EtOH_High, and
EtOH_Low) that were divided into 2 subgroups (18 h and 5 days of
withdrawal) (N = 6 per subgroup). The choice of these two temporal
marks within the withdrawal period was due to the kinetic aspects of
FosB and DeltaFosB expression after 18 h of withdrawal (as explained
in the discussion section), and after 5 days of withdrawal, based on pre-
vious studies from our Lab that investigated some neurochemical fea-
tures regarding withdrawal period within the locomotor sensitization
paradigm (Fallopa et al., 2012; Escosteguy-Neto et al., 2012). Finally,
to perform correlations between locomotor sensitization and FosB/
DeltaFosB expression, we calculated the score of locomotor sensitiza-
tion for each animal, by the formula: score = (Locomotion in the 21st
day− Locomotion in the 1st day) *100/Locomotion in the 1st day.
2.3. Immunohistochemistry
After the respective withdrawal period, animals were deeply anes-
thetized with a cocktail containing ketamine (75 mg/kg, i.p.) and
xylazine (25 mg/kg, i.p.). After the loss of corneal reﬂex, they were per-
fused transcardially with 100 ml of phosphate buffer solution 0.1 M
[phosphate buffered saline (PBS)], followed by 100 ml of 4% parafor-
maldehyde (PFA). The brains were removed immediately after perfu-
sion, stored in PFA for 24 h and then kept in a 30% sucrose/PBS
solution for 48 h. Serial coronal sections (30 μm)were cut using a freez-
ing microtome and kept inside an anti-freezing solution to be used in
the immunohistochemistry procedures by free-ﬂoating staining.
For immunohistochemistry, a conventional technique of avidin–bio-
tin–immunoperoxidase was performed. The brain sections of all exper-
imental groups were included in the same run, being pretreated with
hydrogen peroxidase (3%) for 15 min and then washed with PBS for
30 min. Then, all sections were exposed during 30 min in a PBS-BSA
.5% to avoid nonspeciﬁc reactions. Thereafter, sections were incubated
overnight with the primary antibody rabbit anti-FosB/DeltaFosB
(1:3,000; Sigma Aldrich, St Louis, MO, USA. no.cat. AV32519) in PBS-T
solution (30 ml PBS, 300 μl Triton X-100). Subsequently, sections
were incubated for 2 h in a biotinylated goat anti-rabbit IgG secondary
antibody (1:600; Vector, Burlingame, CA, USA) at room temperature.
The sections were then treated with avidin–biotin complex (Vectastain
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ted to nickel-intensiﬁed diaminobenzidine reaction. Between steps, the
sections were rinsed in PBS and agitated on a rotator. Sections were
mounted on gelatin-coated slides, dried, dehydrated and coverslipped.
The following encephalic regions were analyzed: prefrontal cortex
[anterior cingulate cortex (Cg1), prelimbic cortex (PrL) and infralimbic
cortex (IL)], motor cortex [primary (M1) and secondary (M2)], dorsal
striatum [dorsomedial striatum (DmS) and dorsolateral striatum
(DlS)], ventral striatum [nucleus accumbens core (Acbco) and shell
(Acbsh), ventral pallidum (VP)], hippocampus [pyramidal layer of
Cornus Ammong 1 and 3 (CA1 and CA3, respectively), granular layer
of dentate gyrus (DG)], amygdala [basolateral nucleus (BlA), and central
nucleus (CeA)], ventromedial nucleus of hypothalamus (VMH) and
ventral tegmental area [anterior (VTAA) and posterior (VTAP) portions]
(See Fig. 1). A Nikon Eclipse E200 microscope connected to a computer
was used to capture images from each section at a ×20 magniﬁcation.
The images were saved as .tiff archives for posterior analysis of FosB/
DeltaFosB immunoreactivity. The immunoreactive cells were counted
using the ImageJ software (NIH Image, Bethesda, MD, USA). The brain
regions were delineated on each photograph according to The Stereo-
taxic Mouse Brain Atlas (Franklin and Paxinos, 1997). Since photomi-
crographies taken by the microscope represents 2.5 × 103 μm2 in a
20× magniﬁcation, the quantiﬁcation of FosB/DeltaFosB labeled cells is
expressed as the average of immunostaining cells per 2.5 × 103 μm2.
The values obtained in the EtOH groups were normalized to the Control
values, and expressed as %. (Control = 100%).
2.4. Statistical analysis
Initially, Shapiro–Wilk was used to verify the normality of distribu-
tion of all variables. The behavioral results were analyzed by one-way
ANOVA for repeatedmeasure considering as factor the 5 periods of loco-
motor sensitization: basal, day 1, day 7, day 14, and day 21. The histolog-
ical results were analyzed by two-way ANOVA, considering as factors:
period of withdrawal (18 h and 5 days) and experimental group (Con-
trol, EtOH_High andEtOH_Low). Thenonparametric variableswere stan-
dardized into Z scores in order to decrease the dispersion of data, and
subsequently applied in the two-way ANOVA, as previously described.
Newman Keuls post-hocwas used when necessary. Finally, we investi-
gated possible correlations between FosB/DeltaFosB positive cells and
the scores of locomotor sensitization. These correlations were calculated
only for the nuclei where statistical differences between experimental
groups had been found. Because these differences were restricted to
the 5 days ofwithdrawal (See results section), the FosB/DeltaFosB values
considered in these correlations refer to this speciﬁc period of time of
withdrawal. Because these differences were restricted to the 5 days of
withdrawal (See results section), the FosB/DeltaFosB values considered
in these correlation refer to this speciﬁc time of withdrawal. The signiﬁ-
cance level was set at 5% (p b0.05).
3. Results
3.1. Locomotor sensitization
ANOVA for repeatedmeasures detected signiﬁcant differences in the
group factor [F(2,32) = 68.33, p b 0.001], in the period of protocolFig. 1. Schematic representation of the brain regions sampled. Schematic drawing of mice
brain coronal sections indicating areas sampled (adapted from Franklin and Paxinos,
1997). M1 = primary motor cortex; M2 = secondary motor cortex, CG1 = anterior cin-
gulate cortex, PrL = prelimbic cortex, IL = infralimbic cortex, Acbco = nucleus accum-
bens core, Acbsh = nucleus accumbens shell, VP = ventral pallidum DmS =
dorsomedial striatum, DlS = dorsolateral striatum, CA1 = Cornus Ammonis 1, CA3 =
Cornus Ammonis 3; DG = granular layer of dentate gyrus, BlA = basolateral nucleus of
amygdala, CeA = central nucleus of amygdala, VmH = ventromedial hypothalamic nucle-
us, VTAA = anterior portion of ventral tegmental area, VTAP = posterior portion of ventral
tegmental area.
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[F(8,128) = 13.34, p b 0.001]. There were no differences in the basal lo-
comotion, and both EtOH groups had similar increases in locomotion in
the ﬁrst day of acquisition, when compared to the Control group
(p b 0.01). However, EtOH_High (but not EtOH_Low) presented a pro-
gressive increase in locomotor activity throughout acquisition phase
(p b 0.01, in relation to Control and EtOH_Low groups, in the last day
of acquisition; p b 0.01 in relation to its locomotor activity in the ﬁrst
day of acquisition) (Fig. 2). These data corroborated the results from
the original study (Masur and dos Santos, 1988) and from our previous
report (Coelhoso et al., 2013) concerning behavioral variability in out-
bred Swiss mice submitted to ethanol-induced locomotor sensitization.3.2. FosB/DeltaFosB expression
The illustrative photomicrographics of FosB/DeltaFosB immunoreac-
tivity are depicted in Fig. 3 and the normalized values are shown in
Figs. 4, 5, 6 and 7. Two-way ANOVA detected signiﬁcant differences in
the M1, M2, DmS, DlS, Acbco, Acbsh, VP and VTA (for non-normalized
values of FosB/DeltaFosB immunoreactivity and statistical analyses of
all structures, see Table Suppl1 and Table 1, respectively). In the struc-
tures where statistical differences could be observed, there were four
different patterns of FosB/DeltaFosB expression. In the ﬁrst one, ob-
served in M1 and M2, there was an increase in FosB/DeltaFosB expres-
sion in the ﬁfth day of ethanol withdrawal only in the EtOH_High
group (compared to EtOH_High values at 18 h of withdrawal, as well
as, to the Control and EtOH_Low groups at 5 days of withdrawal) (see
Fig. 4). In the second pattern, observed in the VTAA, FosB/DeltaFosB ex-
pression increased at 5 days of ethanol withdrawal only in the
EtOH_Low group (compared to EtOH_Lowvalues at 18 h ofwithdrawal,
as well as, to the Control group at 5 days of withdrawal) (see Fig. 5). In
the third pattern, observed in the DmS, Acbco, and Acbsh, FosB/
DeltaFosB expression increased at 5 days of ethanol withdrawal in
both EtOH_High and EtOH_Low groups (compared to their respective
values at 18 h of withdrawal), however, only EtOH_Low group differed
from Control group (see Fig. 6). Finally, in the fourth pattern, observed
in DlS and VP, FosB/DeltaFosB expression increased at 5 days of ethanol
withdrawal in both EtOH_High and EtOH_Low groups (compared to
their respective values at 18 h of withdrawal), although this increase
was statistically more expressive in EtOH_Low than in EtOH_High
group, and only EtOH_Low group differed from Control group (see
Fig. 7).Fig. 2. Ethanol promotes a gradual and robust increase of locomotion throughout chronic
treatment in EtOH_High, but not in EtOH_Low group. The data were expressed as
mean ± S.E.M.N = 12 for Control, EtOH_High and EtOH_Low groups. ⁎⁎ P b 0.01 in rela-
tion to Control group, at the same period. ## P b 0.01 in relation to EtOH_Low group, at
the same period. ‡‡ P b 0.01 in relation to basal locomotor activity, within the same
group. ¥¥ P b 0.01 in relation to locomotor activity on the 1st day of acquisition, within
the same group.To conﬁrm that changes in FosB/DeltaFosB expression were due
to withdrawal, and not to ethanol exposure, we performed correla-
tions between the score of locomotor sensitization and the FosB/
DeltaFosB immunolabelled cells at the 5th day of withdrawal in the
nuclei above mentioned (M1, M2, Acbco, Acbsh, DmS, DlS, VP,
VTAA). As expected, there were no signiﬁcant correlations for any
of these nuclei (M1 — r2 = 0.027862, p = 0.987156; M2 —
r2 = 0.048538, p = 0.196646; Acbco — r2 = 0.001920, p =
0.799669; Acbsh — r2 = 0.006743, p = 0.633991; DmS — r2 =
0.015880, p = 0.463960; DlS — r2 = 0.023991, p = 0.914182; VP —
r2 = 0.002210, p = 0.785443; VTAA— r2 = 0.001482, p = 0.823630).
4. Discussion
The results observed in the present study suggest that the increased
expression of FosB/DeltaFosB observed in the ethanol-induced locomo-
tor sensitization paradigm is likely to be related to withdrawal rather
than to chronic drug exposure. However, the behavioral variability in
the development locomotor sensitization was accompanied by distinct
patterns of FosB/DeltaFosB expression during withdrawal. The role of
motor cortex, ventral tegmental area and striatum in the acquisition
and expression of locomotor sensitization paradigm is well established
(Vanderschuren and Pierce, 2010). Furthermore, deregulation of
mesolimbic pathway is one of the central neurobiological features of
withdrawal period, together with the emergence of extended amygdala
(Koob and Le Moal, 2005, 2008). However, only few studies explored
thewithdrawal period of the locomotor sensitization paradigm. Our re-
sults encountered interesting changes in FosB/DeltaFosB expression in
the motor cortex, ventral tegmental area, and striatum within this
period.
FosB cDNA encodes the expression of 33, 35, and 37 kDa proteins.
Acute stimuli exposure leads strong 33- and discrete 35- and 37- kDa
Fos protein induction. As a consequence, under acute activation, the
predominant FosB expression is related to 33 kDa (McClung et al.,
2004; Nestler, 2008). There is another remarkable difference between
these proteins: only 35–37 kDa proteins are highly stable isoforms. Be-
cause of this high stability, these truncated forms of FosB, also called
DeltaFosB, accumulate in the brain and are highly expressed in response
to chronic stimuli, such as psychotropic drug treatments, chronic elec-
troconvulsive seizures, and stress (Kelz and Nestler, 2000; Nestler
et al., 2001; McClung et al., 2004). As a consequence, DeltaFosB have
been viewed as a sustained molecular switch to mediate forms of
long-lasting neural and behavioral plasticity. Interestingly, an elegant
study using mouse lines expressing differentially FosB and DeltaFosB
showed that FosB is essential for the enhancement of stress tolerance
and also neutralizes the correlation between psychostimulant-induced
locomotor sensitization and accumulation of DeltaFosB in the striatum
(Ohnishi et al., 2011). Therefore, both proteins could play important
roles in the experimental protocol used in the present study. It is note-
worthy that the FosB antibodyused recognizes both FosB andDeltaFosB.
Since FosB diminishes to baseline levels within 6 h after an acute stim-
ulus (Nestler et al., 2001) and DeltaFosB accumulate after repeated
stimuli exposures, we decided to sacriﬁce the animals 18 h after the ac-
quisition phase, to avoid possible biases of ethanol treatment over FosB
expression. Nonetheless, to be technically precise, we will refer in the
present study as FosB/DeltaFosB expression. It is important to note
that this strategy has been used in others studies, including those that
used the same primary antibody described here (Conversi et al., 2008;
Li et al., 2010; Flak et al., 2012; García-Pérez et al., 2012). As a conse-
quence, besides these experimental limitations, we will discuss our re-
sults considering the role of DeltaFosB in neuronal plasticity.
It is well established that chronic drug exposure increases FosB/
DeltaFosB expression in several regions of brain (Nestler et al., 2001;
Perrotti et al., 2008). Curiously, in the present study neither ethanol sen-
sitized nor ethanol non-sensitized mice differed from chronic saline
treatedmice regarding FosB/DeltaFosB expression 18 h after acquisition
Fig. 3. Illustrative photomicrography of FosB/DeltaFosB immunoreactivity at ×20 ofmagniﬁcation. DmS = dorsomedial striatum; DlS = dorsolateral striatum; Acbco = nucleus accum-
bens core; Acbsh = nucleus accumbens shell; VP = ventral pallidum; VTAa = anterior portion of ventral tegmental area.
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FosB/DeltaFosB expression and the scores of locomotor sensitization.
This divergence could be explained, at least partially, by the differences
found in the experimental protocol. For example, considering the etha-
nol exposure, in two studies the two bottle free choice paradigm was
used in 15 intermittent drinking sessions (Li et al., 2010) or nutritionally
complete liquid diet auto-administered during 17 days (where animalsconsume ethanol at doses ranging from 8 to 12 g/kg/day) (Perrotti
et al., 2008). In another study, although the authors refer to chronic
treatment, the protocol consisted in only 4 ethanol exposures
(Ryabinin and Wang, 1998). So, protocols used elsewhere are totally
distinct from the one used here, which consisted of 21 days of treat-
ment where daily ethanol injections were administered by an experi-
menter. Despite these differences, there are several studies involving
Fig. 4. Expression of FosB/DeltaFosB at 18 h and 5 days of withdrawal period in
EtOH_High and EtOH_Low groups in the M1 and M2. The data were expressed as
mean ± S.E.M. and represent the normalized data according to the values of Control
groups (dotted line — considered as 100%). Grey bars = 18 h of ethanol withdrawal;
Black bars = 5 days of ethanol withdrawal. ** P b 0.01 in relation to its respective Control
group; ## P b 0.01, in relation to its respective value at 18 hours of withdrawal. ‡‡
P b 0.01, in relation to EtOH_Low group within the same period. M1 = primary motor
cortex, M2 = secondary motor cortex.
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sion after protocols of locomotor sensitization induced by psycho-
stimulants (Brenhouse and Stellar, 2006; Conversi et al., 2008; Vialou
et al., 2012) and opioids (Kaplan et al., 2011). However, the protocols
of locomotor sensitization in those studies involve much less than 21
drug exposures, and in some of them, drug was administered in an in-
termittent way. In contrast, our protocol used the same treatment de-
scribed in previous studies involving 21 daily ethanol injections
(Masur and Dos Santos, 1988; Souza-Formigoni et al., 1999; Quadros
et al., 2002a, 2002b; Abrahão et al., 2011, 2012). There is evidence
that although chronic cocaine administration promotes accumulation
of DeltaFosB expression in the nucleus accumbens, it also promotes tol-
erance to DeltaFosB mRNA induction in both ventral and dorsal stria-
tum (Larson et al., 2010). Therefore, we hypothesized that the lack of
differences in our experimental groups in the acquisition phase might
be due to a tolerance regarding FosB/DeltaFosB induction, since in the
present protocol there was a larger period of acquisition phase com-
pared to periods used for psychostimulant and opioids in other studies.Fig. 5. Expression of FosB/DeltaFosB at 18 h and 5 days of withdrawal period in
EtOH_High and EtOH_Low groups in the VTA. The data were expressed as mean ± S.E.M.
and represent the normalized data according to the values of Control groups (dotted line
— considered as 100%). Grey bars = 18 h of ethanol withdrawal; Black bars = 5 days of
ethanol withdrawal. ** P b 0.01 in relation to its respective Control group; ## P b 0.01, in
relation to its respective value at 18 h of withdrawal. VTA = ventral tegmental area.Studies using knockout and transgenic mice showed that FosB mu-
tant mice have enhanced behavioral response to cocaine, such as stim-
ulant locomotor effects and conditioned place preference. Furthermore,
the expression of both basal and cocaine-inducible DeltaFosB is absent
in this mutant mice (Hiroi et al., 1997). In contrast, transgenic mice
with inducible overexpression of DeltaFosB show increased sensitivity
to the rewarding effects of cocaine and morphine (Muschamp et al.,
2012). These results provided direct evidence of close correlation
between DeltaFosB and the rewarding process. Besides repeated drug
exposures, chronic stress also increases DeltaFosB expression in
corticolimbic circuits (Perrotti et al., 2004). Interestingly, transgenic
mice overexpressing DeltaFosB are less sensitive to the pro-depressive
effects of kappa-opioid agonist, known to induce dysphoria and
stress-like effects in rodents (Muschamp et al., 2012). So, besides re-
ward process, DeltaFosB also plays a pivotal role in the emotional as-
pects of the phenomena. In this scenario, withdrawal could also
trigger FosB/DeltaFosB expression, since stress is a key component of
drug's withdrawal. This perspective is in accordance to our results, be-
cause there were no correlations between FosB/DeltaFosB expression
and the scores of sensitization, and furthermore the increase in FosB/
DeltaFosB expression was observed only on the ﬁfth day of withdrawal.
Interestingly, in some structures, FosB/DeltaFosB increases were
seen in both EtOH_High and EtOH_Low group, although more expres-
sive in the former group, suggesting that these increases could have dif-
ferent functional consequences, according to their intensity. This
hypothesis could be explained by several distinct functional roles of
FosB/DeltaFosB. For example, rats chronically exposed to cocaine had
increased DeltaFosB expression in the nucleus accumbens during with-
drawal period, an effect positively correlated with cocaine preference,
but negatively with novelty preference. Furthermore, stress during
withdrawal increases the behavioral response to psychostimulants by
increasing DeltaFosB expression in corticolimbic neurons (Nikulina
et al., 2012). So, DeltaFosB could predict the dysregulation of hedonic
processing that occurs during protracted withdrawal (Marttila et al.,
2007). On the other hand, both resilience to stress and antidepressant
responses are related to higher DeltaFosB expression in striatum
(Vialou et al., 2010). Therefore, we speculate that increased FosB/
DeltaFosB on striatum in the EtOH_High could have enhanced the re-
warding effects of ethanol, conferring a higher susceptibility to subse-
quent drug exposures. On the other side, a more intense increase in
FosB/DeltaFosB seen in the EtOH_Low group could have decreased the
sensitivity to both dysphoria and stress effects, minimizing negative re-
inforcement effects of subsequent drug exposure and, as a consequence,
explaining a higher resistance in this group. Interestingly, this paradox
had a neurochemical basis. For example, transgenic mice overexpress-
ing FosB in medium spine GABAergic neurons of nucleus accumbens
had increased levels of both mu- and kappa- opioid receptors (Sim-
Selley et al., 2011), and those receptors respectively increase and inhibit
mesolimbic tone (Manzanares et al., 1991; Devine et al., 1993). Further-
more, the cell type expression could also drastically change the func-
tional consequences of the increased FosB/DeltaFosB. In an elegant
study using mice overexpressing DeltaFosB in D1- or D2- expressing
neurons in the nucleus accumbens revealed that DeltaFosB in the D1-
(but not in the D2-) neurons enhances behavioral responses to cocaine
(Grueter et al., 2013).
Curiously, regarding themotor cortex, therewas an increase in FosB/
DeltaFosB expression only in EtOH_High group, and it was restricted to
the 5th day of withdrawal. The lack of increase at 18 h of withdrawal
could be explained by a possible tolerance mechanism in the FosB/
DeltaFosB expression in this region after chronic ethanol exposure. Fur-
thermore, our results suggest that there are active neurochemical
changes in the motor cortex during withdrawal period, despite the
fact that the animalswere notmanipulated during this period. This is in-
teresting, because this plasticity could play a role, at least partially, in
the maintenance of locomotor sensitization. Although the sustained
hyperlocomotion after several days of withdrawal was not studied
Fig. 6. Expression of FosB/DeltaFosB at 18 h and5 days ofwithdrawal period in EtOH_High andEtOH_Lowgroups in theAcbco, Acbsh andDmS. The datawere expressed asmean ± S.E.M.
and represent the normalized data according to the values of Control groups (dotted line— considered as 100%). Grey bars = 18 h of ethanol withdrawal; Black bars = 5 days of ethanol
withdrawal. * P b 0.05 ** P b 0.01, in relation to its respective Control group; ## P b 0.01, in relation to its respective value at 18 h of withdrawal. Acbco = nucleus accumbens core,
Acbsh = nucleus accumbens shell, DmS = dorsomedial striatum.
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showing that sensitizedmice (but not non-sensitized) had enhanced lo-
comotion when challenged with ethanol after a given withdrawal peri-
od (Masur and dos Santos, 1988; Souza-Formigoni et al., 1999; Quadros
et al., 2002a,2002b; Abrahão et al., 2011, 2012; Fallopa et al., 2012;
Coelhoso et al., 2013).
Finally, it is noteworthy that only the EtOH_Low group displayed an
increased FosB/DeltaFosB expression in the anterior (but not posterior)
portion of the ventral tegmental area. These portions have distinctFig. 7. Expression of FosB/DeltaFosB at 18 h and 5 days of withdrawal period in
EtOH_High and EtOH_Low groups in the VP and DlS. The data were expressed as
mean ± S.E.M. and represent the normalized data according to the values of Control
groups (dotted line — considered as 100%). Grey bars = 18 h of ethanol withdrawal;
Black bars = 5 days of ethanol withdrawal. ** P b 0.01 in relation to its respective Control
group; # P b 0.05 ## P b 0.01, in relation to its respective value at 18 h of withdrawal. ‡‡
P b 0.01, in relation to EtOH_Low group within the same period. VP = ventral pallidum,
DlS = dorsolateral striatum.projections and neurochemical proﬁles, and their participation in the re-
ward process depends on several factors (Ikemoto, 2007). For example,
rats' self-administration of ethanol is related to the posterior, but not to
the ventral portion of the ventral tegmental area (Rood-Henricks et al.,
2000; Rood et al., 2004). Furthermore, the endocannabinoid system, as
well as GABA-A, dopaminergic D1-D3, and serotoninergic 5HT3 recep-
tors, plays an important role in ethanol seeking behavior (Linsenbardt
and Boehm, 2009; Rood et al., 2010; Melón and Boehm, 2011b; Hauser
et al., 2011). However, GABA-B in the anterior portion of ventral tegmen-
tal area is important in terms of the rewarding (Moore and Boehm,
2009) and stimulant locomotor effects (Boehm et al., 2002) of ethanol.
Furthermore, cholinergic nicotinic receptors in the anterior portion are
involved in the increased accumbal dopamine levels induced by ethanol
(Ericson et al., 2008). Therefore, regardless the distinct proﬁle of these
portions, it is possible that changes seen in the EtOH_Low group in the
anterior portions could be related to the rewarding process. Chronic
cocaine but not chronic morphine or chronic stress exposure
increases DeltaFosB in ventral tegmental area, speciﬁcally in a
gamma-aminobutyric acid (GABA) cell population (Perrotti et al.,
2005). This fact could explain the normal levels of FosB/DeltaFosB
throughout withdrawal encountered in ventral tegmental area of
EtOH_High mice, regardless the putative high stress experience in this
period. Furthermore, this data corroborates, at least partially, the hy-
pothesis that the increase of FosB/DeltaFosB expression throughout
withdrawal in EtOH_Low could be characterized as being an adaptive
response.
Individual differences observed during the transition from recrea-
tional use to drug addiction are remarkable (Flagel et al., 2009; George
and Koob, 2010; Swendsen and Le Moal, 2011). As a consequence, it is
imperative to study the neurobiological features related to individual
variability. Behavioral sensitization is an animal model commonly
used to investigate the neurobiological features of drug addiction. The
basis of this model is that the subjective effects of the drugs increase
along their repeated exposure. Once acquired, locomotor sensitization
is long lasting and is in direct temporal relation with morphological
and neurochemical changes in the mesolimbic pathway and several
encephalic nuclei related to emotionality and motor behavior
(Robinson and Kolb, 1999; Vanderschuren and Pierce, 2010). A pioneer
study conducted by Masur and dos Santos (1988) demonstrated that
Table 1
Statistical parameters obtained in the two-way ANOVA regarding the analysis of FosB/
DeltaFosB expression.
Nucleus Period factor Treatment factor Period*Treatment
M1 F(1,30) = 5.61,
P = 0.025
F(2,30) = 3.21,
P = 0.055
F(2,30) = 2.61,
P = 0.089
M2 F(1,30) = 4.72,
P = 0.038
F(2,30) = 1.53,
P = 0.233
F(2,30) = 3.45,
P = 0.045
CG1 F(1,30) = 11.08
P = 0.002
F(2,30) = 0.95,
P = 0.398
F(2,30) = 3.31,
P = 0.050
PrL F(1,30) = 8.53,
P = 0.007
F(2,30) = 1.72,
P = 0.197
F(2,30) = 2.74,
P = 0.081
IL F(1,30) = 3.77,
P = 0.062
F(2,30) = 1.91,
P = 0.167
F(2,30) = 0.98,
P = 0.389
Acbco F(1,30) = 22.23
P b 0.001
F(2,30) = 2.63,
P = 0.089
F(2,30) = 5.68,
P = 0.008
Acbsh F(1,30) = 50.44
P b 0.001
F(2,30) = 4.27,
P = 0.023
F(2,30) = 13.18,
P b 0.000
VP F(1,30) = 38.01
P b 0.001
F(2,30) = 5.07,
P = 0.013
F(2,30) = 10.93,
P b 0.000
DmS F(1,30) = 28.89
P b 0.001
F(2,30) = 3.75,
P = 0.035
F(2,30) = 7.71,
P = 0.002
DlS F(1,30) = 13.58
P = 0.001
F(2,30) = 5.41,
P = 0.011
F(2,30) = 4.72,
P = 0.017
CA1 F(1,30) = 4.81,
P = 0.036
F(2,30) = 7.37,
P = 0.002
F(2,30) = 1.62,
P = 0.215
CA3 F(1,30) = 14.92
P = 0.001
F(2,30) = 2.46,
P = 0.102
F(2,30) = 3.81,
P = 0.034
DG F(1,30) = 0.59,
P = 0.447
F(2,30) = 1.49,
P = 0.241
F(2,30) = 0.24,
P = 0.785
BlA F(1,30) = 6.47,
P = 0.016
F(2,30) = 0.12,
P = 0.884
F(2,30) = 1.71,
P = 0.199
CeA F(1,30) = 2.55,
P = 0.121
F(2,30) = 0.22,
P = 0.801
F(2,30) = 0.71,
P = 0.501
VmH F(1,30) = 6.51,
P = 0.016
F(2,30) = 0.71,
P = 0.503
F(2,30) = 1.75,
P = 0.192
VTAA F(1,30) = 9.64,
P = 0.004
F(2,30) = 3.76,
P = 0.035
F(2,30) = 2.65,
P = 0.087
VTAP F(1,30) = 6.05,
P = 0.021
F(2,30) = 1.79,
P = 0.184
F(2,30) = 1.64,
P = 0.211
M1 = primary motor cortex; M2 = secondary motor cortex, CG1 = anterior cingulate
cortex, PrL = prelimbic cortex, IL = infralimbic cortex, Acbco = nucleus accumbens
core, Acbsh = nucleus accumbens shell, VP = ventral pallidum DmS = dorsomedial
striatum, DlS = dorsolateral striatum, CA1 = Cornus Ammonis 1, CA3 = Cornus
Ammonis 3; DG = granular layer of dentate gyrus, BlA = basolateral nucleus of
amygdala, CeA = central nucleus of amygdala, VmH = ventromedial hypothalamic
nucleus, VTAA = anterior portion of ventral tegmental area; VTAP = posterior portion
of central tegmental area.
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ethanol-induced locomotor sensitization. From then on other studies
have demonstrated an important correlation between neurochemical
features and behavioral variability, mainly those related to the dopami-
nergic (Abrahão et al., 2011, 2012; Souza-Formigoni et al., 1999) and the
glutamatergic systems (Quadros et al., 2002). Furthermore, a previous
study from our laboratory using the ethanol-induced locomotor sensiti-
zation paradigm showed that sensitized (but not non-sensitized) mice
presented a remarkable increase on cannabinoid receptor type 1
(CB1R) during the withdrawal period (Coelhoso et al., 2013). Here we
identiﬁed different patterns of FosB/DeltaFosB expression during with-
drawal between EtOH_High and EtOH_Low groups.
To summarize, behavioral variability observed in acquisition phase
of ethanol induced locomotor sensitization is accompanied by distinct
neuronal plasticity during withdrawal period. Interestingly, our results
suggest that different patterns of FosB/DeltaFosB expression detected
in sensitized and non-sensitized mice are more related to withdrawal
period rather than to the chronic drug exposure, probably due to the tol-
erance of drug-induced FosB/DeltaFosB transcription.
Supplementary data to this article can be found online at http://dx.
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